GLP-1 therapy contributes the gastrointestinal side effects characteristic of the class: nausea (particularly during dose escalation), occasional vomiting, constipation, and reduced appetite that is the desired effect but can be excessive in some patients
These may include breathlessness on activity, a fast heartbeat, pale skin, or feeling faint
Whilst B12 injections (hydroxocobalamin) are licensed NHS medicines for treating confirmed deficiency states such as pernicious anaemia, lipotropic injections lack MHRA marketing authorisation and robust clinical evidence
For those who experience fatigue or lethargy due to B12 deficiency, injections can provide a rapid energy boost, helping you feel more alert and active throughout the day
The product has contraindications
[PMID: 24249744]( Stabler SP